Publicacións en colaboración con investigadores/as de Instituto Maimónides de Investigación Biomédica de Córdoba (4)

2024

  1. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

2022

  1. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

2020

  1. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

    United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066

2019

  1. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?

    Journal of Clinical Apheresis, Vol. 34, Núm. 6, pp. 680-685